The pharmaceutical vials market is estimated to be worth USD 15.8 billion in 2030, predicts Roots Analysis

Given the high demand for parenteral formulations and rising vaccination campaigns, there is an urgent need for safe and high-quality pharmaceutical vials for storing and distributing such formulations in large quantities

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Pharmaceutical Vials Market, 2021 – 2030.”

 

The report features an extensive study of the current market landscape and future potential of pharmaceutical vials over the next decade. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes:

§  A detailed assessment of the current market landscape of pharmaceutical vials. 

§  A competitiveness analysis of pharmaceutical vial manufacturers, segmented into four categories, namely small, mid-sized companies, and large and very large companies.

§  Elaborate profiles of prominent players engaged in the development of pharmaceutical vials, based in North America, Europe and Asia Pacific (shortlisted on the basis of the number of pipeline products).

§  An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2015-2021 (till September).

§  An elaborate discussion on the key trends that are likely to have an impact on the future adoption of innovative primary packaging systems.

§  An in-depth analysis to estimate the current and future demand for pharmaceutical vials based on various relevant parameters, for the period 2021-2030.

§  A case study on the use of robotic machinery in pharmaceutical manufacturing and fill / finish operations, highlighting the advantages of using automation / automated technologies in such processes.

§  A case study on pre-sterilized / RTU pharmaceutical vials that are available nowadays.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

  • Type of Fabrication Material Used 

§  Glass

§  Plastic

  • Sterilization Status

§  Pre-sterilized

§  Unsterilized

  • Key Geographical Region 

§  North America

§  Europe

§  Asia Pacific

§  Latin America

§  Middle East and North Africa

§  Rest of the World 

 

Key companies covered in the report

§  Chongqing Zhengchuan Pharmaceutical Packaging

§  Corning

§  DANYANG XIANGHE PHARMACEUTICAL PACKAGING

§  DWK Life Sciences

§  Gerresheimer

§  Ningbo Zhengli Pharmaceutical Packaging

§  Nipro

§  Origin Pharma Packaging

§  Pacific Vial Manufacturing

§  SCHOTT

§  SGD Pharma

§  Shandong Pharmaceutical Glass

§  Stevanato Group

§  Thermo Fisher Scientific

§  Worldwide Glass Resources

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/global-pharmaceutical-vials-market.html

 

Other Recent Offerings

1.     Global Autoinjectors Market (4th Edition): Industry Trends and Global Forecasts, 2021-2035

2.     At-Home Blood Collection and Micro Sampling Devices Market: Industry Trends and Global Forecasts, 2021-2030

3.     Bioprocess Controllers and Automation Systems Market: Industry Trends and Global Forecasts, 2021-2030

4.     Novel Ocular Drug Delivery Devices Market: Industry Trends and Global Forecasts, 2021-2030

5.     Novel Drug Reconstitution Systems Market: Industry Trends and Global Forecasts, 2021-2030

6.     Pre-Sterilized / Ready-to-Use Primary Packaging Market: Focus on Cartridges, Syringes and Vials

7.     (2nd Edition), 2021-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com 

Comments

Post a Comment

Popular posts from this blog

A relatively larger proportion of these firms are headquartered in the US, claims Roots Analysis

  Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.   To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html   The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments: ·        Type of Modular Construct  §   Hybrid Skid §   Plug-and-Play §   Skid-Mounted §   Truckable §   Others §   Type of Construc...
Read more

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030

    Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals   Roots Analysis is pleased to announce the publication of its recent study, titled “ Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 ” report to its list of offerings.   The report provides a detailed study on the current market landscape and future potential of biologics designed for subcutaneous administration. In addition, the study provides an in-depth analysis of the formulation technologies and drug delivery systems (focusing on large volume wearable injectors, autoinjectors, pen injectors, needle-free injectors, drug reconstitution systems, prefilled syringes and implants) that enable subcutaneous delivery of the biologic drugs. Amongst other elements, the r...
Read more

PRE-INSTALLED SINGLE-USE SENSORS FOR BIOPROCESSING-CASE STUDY

    During our research, we identified 31 pre-installed single-use sensors developed by various companies for bioprocessing. The current market landscape is predominantly characterized by the presence of large (38%) and small (37%) players. Notable examples of large players in this domain include ( in alphabetical order ) Cytiva Life Sciences (US), Hamilton (US) and Pall (US).   To Request Sample Pages -: https://www.rootsanalysis.com/reports/single-use-sensors-for-bioprocessing.html       Majority of the pre-installed single-use sensor systems are designed for both, research and biomanufacturing purposes. This is followed by those designed for only research purposes. Notable examples of products which are developed for both research and biomanufacturing applications, include ( arranged alphabetically ) ÄKTA ready XL sensor technology (Cytiva Life Sciences), Allegro™ MVP Single-Use System (Pall Corporation) and FUTURA pico (Aber Instruments)...
Read more